Yahoo Finance

The Corus(R) CAD Gene Expression Test Can Help Commercial Health Plans Reduce Costs by Improving the Accuracy of the Diagnostic Workup in Patients With Suspected Obstructive ...

PALO ALTO, CA--(Marketwired - Feb 26, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced a new publication on the economic utility of ...
FierceBiotech

CardioDx extols virtues of CAD test in new study

It's been a difficult year for CardioDx, but there may be light at the end of the tunnel: In a new study, researchers found that the company's genetic test for coronary artery disease could help ...
Yahoo UK & Ireland

The Corus(R) CAD Gene Expression Test Significantly Correlates With Plaque Burden and Obstructive Coronary Artery Disease as Validated by CT-Angiography

PALO ALTO, CA--(Marketwired - Feb 3, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of a new analysis demonstrating ...
Yahoo Finance

CardioDx Announces Aetna and Coventry Health Coverage for Corus(R) CAD Gene Expression Test

REDWOOD CITY, CA--(Marketwired - Jul 7, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, confirmed today that Aetna has established a clinical policy ...
Fierce Healthcare

CardioDx Announces Medicare Coverage for Corus CAD Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for ...